Document is current
Any future updates will be listed below
-
Authors
Kawahara, Fuko
Shirayama, Rie https://orcid.org/0000-0002-1047-9428
Ito, Takuma
Oshida, Koichi
Sato, Tetsuji
Kusuhara, Koichi
- License Information
-
More Information
Article History
Received: 18 October 2021
Revised: 13 January 2022
Accepted: 13 January 2022
First Online: 25 January 2022
Declarations
:
: FK, RS, TI, KO, and KK have received research grant to the department of pediatrics from Chugai Pharmaceutical Co., Ltd. RS has received payment for lectures on speaker's bureau from Fujimoto Pharmaceutical Corp., Takeda Pharmaceutical Co., Ltd., and Chugai Pharmaceutical Co., Ltd. TI has received payment for lectures on speaker's bureau from Fujimoto Pharmaceutical Corp., Takeda Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Sanofi S.A., and Novo Nordisk A/S. KO has received payment for lectures on speaker's bureau from Takeda Pharmaceutical Co., Ltd., Sanofi S.A., and Chugai Pharmaceutical Co., Ltd. TS has received payment for lectures on speaker's bureau from CSL Behring, Takeda Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Sanofi S.A., Bayer AG, Shire plc, Bioverativ Inc., and Nihon Pharmaceutical Co., Ltd.
